Delante, Mayline .

HRN: 11-29-27  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/18/2022
CEFUROXIME 500MG (TAB)
11/18/2022
11/25/2022
ORAL
500mg/tab
BID
S/P NSVD; THICKLY MSAF
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: